1 active not recruiting, 1 not yet recruiting. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Not yet recruiting 1 |
Follow Intravenous Immunoglobulin: new trials by email Literature Review of Intravenous Immunoglobulin trials Research Report on Intravenous Immunoglobulin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| EFG vs IVIG in TAMG Efgartigimod + Thymectomy, Intravenous immunglobulin + Thymectomy - Efgartigimod, Intravenous Immunoglobulin | Phase 3 | Not yet recruiting | Shanghai Zhongshan Hospital | 64 | 2025-12-01 | 2025-11-17 |
| A Single Cycle of Intravenous Immunoglobulin as Adjuvant to Rituximab in Patients With Pemphigus: A Retrospective Cohort Study at a Tertiary Referral Center Pemphigus Disease, Rituximab (RTx) | Active not recruiting | Ruijin Hospital | 76 | 2019-12-01 | 2025-04-29 |
Pemphigus (1)
Autoimmune Diseases (1) · Immune System Diseases (1) · Skin Diseases (1) · Skin Diseases, Vesiculobullous (1) · Skin and Connective Tissue Diseases (1)
Thymectomy (1)
Ruijin Hospital (1) · Shanghai Zhongshan Hospital (1)
China (2)